• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱内灌注福尔马林治疗宫颈癌放疗后出血性膀胱炎

Intravesical formalin for hemorrhagic cystitis following irradiation of cancer of the cervix.

作者信息

Dewan A K, Mohan G M, Ravi R

机构信息

Department of Genitourinary Surgery, Cancer Institute (WIA), Adyar, Madras, India.

出版信息

Int J Gynaecol Obstet. 1993 Aug;42(2):131-5. doi: 10.1016/0020-7292(93)90626-8.

DOI:10.1016/0020-7292(93)90626-8
PMID:7901061
Abstract

OBJECTIVE

To determine the effectiveness of intravesical formalin instillation in hemorrhagic cystitis following irradiation of cancer of the cervix.

METHOD

Records were reviewed for 35 patients with hemorrhagic radiation cystitis who underwent treatment with 1% (n = 22), 2% (n = 10), and 4% formalin (n = 4), using Fair's technique.

RESULT

Complete response was seen in 31 patients (89%) and partial response in 3 patients (8%) after a single instillation. Minor complications were seen in 19 patients (54%). Major complications occurred in 11 patients (31%), with 5 cases requiring subsequent urinary diversion. One patient died of persistent bleeding and probable formalin toxicity. Hematuria recurred in 7 patients achieving complete response at a mean period of 8 months after treatment. A 1% solution was as effective in controlling hematuria as higher concentrations and was associated with significantly less morbidity.

CONCLUSION

Intravesical instillation of 1% formalin is an effective treatment for intractable hematuria secondary to radiation cystitis.

摘要

目的

确定膀胱内灌注福尔马林治疗宫颈癌放疗后出血性膀胱炎的有效性。

方法

回顾性分析35例接受福尔马林膀胱灌注治疗的放射性出血性膀胱炎患者的记录,其中1%福尔马林组(n = 22)、2%福尔马林组(n = 10)和4%福尔马林组(n = 4),采用Fair技术。

结果

单次灌注后,31例患者(89%)完全缓解,3例患者(8%)部分缓解。19例患者(54%)出现轻微并发症。11例患者(31%)出现严重并发症,其中5例需要随后进行尿流改道。1例患者死于持续性出血及可能的福尔马林毒性。7例完全缓解的患者在治疗后平均8个月出现血尿复发。1%福尔马林溶液在控制血尿方面与高浓度溶液效果相同,且发病率显著较低。

结论

膀胱内灌注1%福尔马林是治疗放射性膀胱炎继发顽固性血尿的有效方法。

相似文献

1
Intravesical formalin for hemorrhagic cystitis following irradiation of cancer of the cervix.膀胱内灌注福尔马林治疗宫颈癌放疗后出血性膀胱炎
Int J Gynaecol Obstet. 1993 Aug;42(2):131-5. doi: 10.1016/0020-7292(93)90626-8.
2
Intravesical instillation of Formalin for hemorrhagic cystitis secondary to radiation for gynecologic malignancies.膀胱内灌注福尔马林治疗妇科恶性肿瘤放疗后继发性出血性膀胱炎。
Gynecol Oncol. 1983 Aug;16(1):31-3. doi: 10.1016/0090-8258(83)90005-7.
3
Intravesical formalin for hemorrhagic cystitis: analysis of therapy.膀胱内灌注福尔马林治疗出血性膀胱炎:治疗分析
J Urol. 1989 Apr;141(4):809-12. doi: 10.1016/s0022-5347(17)41016-0.
4
Innovative use of intravesical tacrolimus for hemorrhagic radiation cystitis.膀胱内使用他克莫司治疗出血性放射性膀胱炎的创新应用。
Int Urol Nephrol. 2015 Oct;47(10):1679-81. doi: 10.1007/s11255-015-1098-6. Epub 2015 Sep 7.
5
Intravesicle formalin instillation with a modified technique for controlling haemorrhage secondary to radiation cystitis.采用改良技术进行膀胱内福尔马林灌注以控制放射性膀胱炎继发的出血。
Asian J Surg. 2002 Jul;25(3):232-5. doi: 10.1016/S1015-9584(09)60181-0.
6
Intravesical lidocaine for formalin-induced suprapubic pain: case report.膀胱内利多卡因治疗福尔马林诱导的耻骨上疼痛:病例报告
Am J Hosp Palliat Care. 2004 Jan-Feb;21(1):58-60. doi: 10.1177/104990910402100113.
7
Phenolization of bladder in treatment of massive intractable hematuria.膀胱石炭酸烧灼术治疗大量顽固性血尿
Urology. 1975 Jan;5(1):119-21. doi: 10.1016/0090-4295(75)90321-0.
8
Intravesical Instillation of Kangfuxin Liquid Combined with Thrombin and Epidermal Growth Factor for Radiation-induced Hemorrhagic Cystitis in Patients with Cervical Cancer: A report of 34 cases.康妇新液联合凝血酶、表皮生长因子膀胱灌注治疗宫颈癌放射性出血性膀胱炎 34 例报告
Bioengineered. 2021 Dec;12(1):815-820. doi: 10.1080/21655979.2021.1882141.
9
Intravesical formalin for the control of intractable bladder haemorrhage secondary to radiation cystitis or bladder cancer.膀胱内灌注福尔马林用于控制放射性膀胱炎或膀胱癌继发的顽固性膀胱出血。
Urol Res. 1979 Jun 22;7(2):125-6. doi: 10.1007/BF00254693.
10
[A case of shock following intravesical formalin instillation].
Hinyokika Kiyo. 1992 Jul;38(7):841-3.

引用本文的文献

1
Advancements in Understanding and Managing Radiation Cystitis: A Comprehensive Review.深入了解和管理放射性膀胱炎:全面综述。
Curr Urol Rep. 2024 Sep 17;26(1):1. doi: 10.1007/s11934-024-01238-0.
2
Hemorrhagic Cystitis: Making Rapid and Shrewd Clinical and Surgical Decisions for Improving Patient Outcomes.出血性膀胱炎:做出快速且明智的临床和手术决策以改善患者预后。
Res Rep Urol. 2023 Jun 29;15:291-303. doi: 10.2147/RRU.S320684. eCollection 2023.
3
Urological complications after radiation therapy-nothing ventured, nothing gained: a Narrative Review.
放射治疗后的泌尿系统并发症——不入虎穴,焉得虎子:一篇叙述性综述
Transl Cancer Res. 2021 Feb;10(2):1096-1118. doi: 10.21037/tcr-20-2589.
4
Chemical hemorrhagic cystitis: Diagnostic and therapeutic pitfalls (Review).化学性出血性膀胱炎:诊断与治疗误区(综述)
Exp Ther Med. 2021 Jun;21(6):624. doi: 10.3892/etm.2021.10056. Epub 2021 Apr 14.
5
Canadian Urological Association Best Practice Report: Diagnosis and management of radiation-induced hemorrhagic cystitis.加拿大泌尿外科协会最佳实践报告:放射性出血性膀胱炎的诊断与管理
Can Urol Assoc J. 2019 Feb;13(2):15-23. doi: 10.5489/cuaj.5788.
6
Cancer survivorship issues with radiation and hemorrhagic cystitis in gynecological malignancies.妇科恶性肿瘤中放疗及出血性膀胱炎相关的癌症生存问题。
Int Urol Nephrol. 2018 Oct;50(10):1745-1751. doi: 10.1007/s11255-018-1970-2. Epub 2018 Aug 21.
7
[Radiation cystitis : Pathophysiology and treatment].[放射性膀胱炎:病理生理学与治疗]
Urologe A. 2017 Mar;56(3):301-305. doi: 10.1007/s00120-017-0319-2.
8
Challenges and Opportunities in Radiation-induced Hemorrhagic Cystitis.放射性出血性膀胱炎的挑战与机遇
Rev Urol. 2016;18(2):57-65. doi: 10.3909/riu0700.
9
A Narrative Review on the Pathophysiology and Management for Radiation Cystitis.放射性膀胱炎的病理生理学与治疗的叙述性综述
Adv Urol. 2015;2015:346812. doi: 10.1155/2015/346812. Epub 2015 Dec 22.
10
A Practical Approach to the Management of Radiation-Induced Hemorrhagic Cystitis.放射性出血性膀胱炎的实用处理方法。
Drugs. 2015 Sep;75(13):1471-82. doi: 10.1007/s40265-015-0443-5.